Page last updated: 2024-08-24

thiazolyl blue and Nasopharyngeal Carcinoma

thiazolyl blue has been researched along with Nasopharyngeal Carcinoma in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Dai, BQ; Feng, LC; Jiang, X1
Chu, QQ; Huang, BJ; Huang, HB; Huang, JL; Huang, TJ; Liu, RY; Peng, LX; Qian, CN; Yang, CF; Yang, GD; Yang, HJ; Zhu, ZY1
Gan, L; Hu, GQ; Hu, GY; Jiang, JZ; Li, WW; Liu, DB; Long, GX; Mei, Q; Sun, W; Wang, JF1
Bu, X; Fan, R; Ma, J; Sun, X; Tong, J; Xu, R; Zhao, D1

Other Studies

4 other study(ies) available for thiazolyl blue and Nasopharyngeal Carcinoma

ArticleYear
LncRNA TP73-AS1 regulates miR-495 expression to promote migration and invasion of nasopharyngeal carcinoma cells through junctional adhesion molecule A.
    The Kaohsiung journal of medical sciences, 2021, Volume: 37, Issue:5

    Topics: Biopsy; Cell Adhesion Molecules; Cell Line, Tumor; Cell Movement; Disease Progression; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Humans; MicroRNAs; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Invasiveness; Neoplasm Metastasis; Protein Binding; Receptors, Cell Surface; RNA, Long Noncoding; Tetrazolium Salts; Thiazoles

2021
Epstein-Barr Virus_Encoded LMP1 upregulates microRNA-21 to promote the resistance of nasopharyngeal carcinoma cells to cisplatin-induced Apoptosis by suppressing PDCD4 and Fas-L.
    PloS one, 2013, Volume: 8, Issue:10

    Topics: Apoptosis; Apoptosis Regulatory Proteins; Blotting, Western; Carcinoma; Cell Line; Cisplatin; Colony-Forming Units Assay; Drug Resistance, Neoplasm; Fas Ligand Protein; Fluorescent Antibody Technique; Forkhead Box Protein O3; Forkhead Transcription Factors; Gene Expression Regulation, Neoplastic; Humans; Inhibitory Concentration 50; Luciferases; MicroRNAs; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA-Binding Proteins; Signal Transduction; Tetrazolium Salts; Thiazoles; Viral Matrix Proteins

2013
Cyclooxygenase-2 inhibitor celecoxib suppresses invasion and migration of nasopharyngeal carcinoma cell lines through a decrease in matrix metalloproteinase-2 and -9 activity.
    Die Pharmazie, 2014, Volume: 69, Issue:2

    Topics: Carcinoma; Celecoxib; Cell Line, Tumor; Cell Movement; Cell Proliferation; Coloring Agents; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Humans; Indicators and Reagents; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Invasiveness; Neoplasm Metastasis; Pyrazoles; Sulfonamides; Tetrazolium Salts; Thiazoles; Wound Healing

2014
A novel multifunctional nanocomposite C225-conjugated Fe3O4/Ag enhances the sensitivity of nasopharyngeal carcinoma cells to radiotherapy.
    Acta biochimica et biophysica Sinica, 2012, Volume: 44, Issue:8

    Topics: Carcinoma; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Enzyme-Linked Immunosorbent Assay; ErbB Receptors; Ferrosoferric Oxide; Humans; Microscopy, Electron, Transmission; Molecular Targeted Therapy; Nanocomposites; Nanotechnology; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Radiation-Sensitizing Agents; Silver; Tetrazolium Salts; Thiazoles; Time Factors

2012